Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, The First Affiliated Hospital of Sun Yat-Sen University, No.58 Zhongshan Road 2, Guangzhou, 510080, People's Republic of China.
Department of Medical Ultrasonics, Guangdong Second People's Hospital, Haizhu District, Guangzhou, 510317, People's Republic of China.
BMC Cancer. 2019 Nov 21;19(1):1135. doi: 10.1186/s12885-019-6355-0.
Post-transplant lymphoproliferative disorders (PTLDs) represent a spectrum of heterogenetic lymphoid proliferations. PTLD is a serious complication that affects the long-term survival of kidney transplant patients. Imaging examination is an important method for detecting and diagnosing PTLD. Contrast-enhanced ultrasonography (CEUS) and CEUS-guided biopsy are important modalities for tumor detection and diagnosis. In this case, we describe a 69 years old man in whom a native kidney PTLD was confirmed by CEUS.
A 69-year-old male patient who had a kidney transplant 1 year earlier presented with 3 months of progressive myasthenia of both lower limbs associated with amyotrophy and weight loss. Although positron emission tomography/computed tomography (PET-CT) showed a high metabolic lesion in the untransplanted kidney, abdominal contrast enhanced computed tomography cannot detect the lesion in the atrophic left kidney. The above examinations showed that the transplanted kidney was normal. CEUS can detect a homogeneously enhanced lesion in the same location as PET-CT. Subsequently, a biopsy was performed under CEUS guidance, and the final pathological diagnosis was diffuse large B-cell lymphoma. The patient then received the R-CHOP treatment. Unfortunately, pulmonary thromboembolism occurred 2 weeks later, and the patient's condition was not alleviated through active treatment. Finally, the patient's family gave up treatment, and the patient was discharged.
The case suggested that CEUS was a valuable imaging method for patient with renal transplantation to detect and diagnose of PTLD.
移植后淋巴组织增生性疾病(PTLD)是一组异质性淋巴增生。PTLD 是一种严重的并发症,影响肾移植患者的长期生存。影像学检查是检测和诊断 PTLD 的重要方法。超声造影(CEUS)和 CEUS 引导下活检是肿瘤检测和诊断的重要手段。在本例中,我们描述了一例经 CEUS 证实的原发性肾移植后 PTLD。
一名 69 岁男性,肾移植 1 年前,出现双下肢进行性肌无力,伴肌萎缩和体重减轻,持续 3 个月。虽然正电子发射断层扫描/计算机断层扫描(PET-CT)显示未移植肾脏有高代谢病变,但腹部增强计算机断层扫描不能检测到萎缩左肾的病变。上述检查显示移植肾正常。CEUS 可检测到与 PET-CT 相同位置的均匀增强病变。随后,在 CEUS 引导下进行活检,最终病理诊断为弥漫性大 B 细胞淋巴瘤。患者随后接受了 R-CHOP 治疗。不幸的是,2 周后发生肺血栓栓塞,经积极治疗后患者病情未缓解。最终,患者家属放弃治疗,患者出院。
该病例提示 CEUS 是肾移植患者检测和诊断 PTLD 的一种有价值的影像学方法。